期刊文献+

慢性丙型肝炎的中西医治疗 被引量:3

Integrated traditional Chinese and western medicine therapy for chronic hepatitis C
下载PDF
导出
摘要 慢性丙型肝炎的西医治疗以干扰素联合利巴韦林的抗病毒治疗为基础。对标准治疗无持续病毒学应答的难治性丙型肝炎,蛋白酶抑制剂等特异性靶向抗病毒治疗有助于HCV的清除,多药联合同时可能加重某些不良反应如皮疹、贫血等,影响治疗的依从性。中西医结合治疗在减轻丙型肝炎抗病毒药物不良反应如发热、肌肉酸痛、抑郁、贫血及白细胞下降等,改善患者对治疗的依从性,提高持续性病毒学应答,减少停药后的复发及保肝抗炎、抗肝纤维化等方面显现一些优势。 The standard treatment of chronic hepatitis C is interferon and ribavirin combination therapy. Specifically targeted antiviral therapies, such as the use of protease inhibitors, are helpful to eliminate HCV in the patients who have failed to achieve sustained virologic response (SVR) with the standard treatment. Drug combination may enhance some adverse reactions such as rash and anemia, and affect the treatment compliance. Integrated treatment of traditional Chinese medicine and western medicine shows some advantages in alleviating adverse reactions of antiviral therapy such as fever, muscular soreness, depression, anemia and aleu- cocytosis, improving treatment compliance and SVR rate, reducing relapse after drug withdrawal as well as achieving hepatoprotec- tion, anti-inflammation and anti-fibrosis.
出处 《传染病信息》 2010年第5期263-265,284,共4页 Infectious Disease Information
基金 国家"十一五"科技重大专项(2008ZX10005-009)
关键词 肝炎 丙型 慢性 中西医结合 治疗学 药物不良反应 hepatitis C, chronic integrated traditional Chinese medicine & western medicine therapeutics adverse drug reactions
  • 相关文献

参考文献25

  • 1中华人民共和国卫生部.卫生部公布2010年1月及2009年度全国法定传染病疫情[EB/OL].[2010-01-25].http://www.moh.gov.cn/publicfiles//business/htmlfiles/wsb/pyqxx/list.htm.
  • 2丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 3Ferenci P,Fried MW,Shiffman ML,et al.Predicting sustained virological responses in chronic hepatitis C patients treated with paginterferon alfa-2a (40 KD)/ribavirin[J].J Hepatol,2005,43(3):425-433.
  • 4Shiffman ML Suter F,Bacon BR,et al.Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3[J].N Engl J Med,2007,357(2):124-134.
  • 5Ferenci P,Laferl H,Scherzer TM,et al.Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients with slow virologic response[J].Gastroenterology,2010,138(2):503-512.
  • 6Fried MW,Jensen DM,Rodriguez-Torres M,et al.Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics:randomized study of higher doses of peginterferon alpha2a and ribavirin[J].Hepatology,2008,48(4):1033-1043.
  • 7Jensen DM,Marcellin P,Freilich B,et al.Re-treatment of patients with chronic hepatitis C who do not respond to peginterferonalpha2,b:a randomized trial[J].Ann Intern Med,2009,150(8):528-540.
  • 8Di Bisceglie AM,Shiffman ML,Everson GT,et al.Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon[J].N Engl J Med,2008,359(23):2429-2441.
  • 9McHutchison JG,Lawitz EJ,Shiffman ML,et al.Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection[J].N Enrl J Med,2009,361(6):580-593.
  • 10Hézode C,Forestier N,Dusheiko G,et al.Telaprevir and poginterferon with or without ribavirin for chronic HCV infection[J].N Engl J Med,2009,360(18):1839-1850.

二级参考文献32

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2尹明实,朴红心,韩学吉,金仁仙.苦参素联合α-干扰素治疗慢性丙型肝炎36例临床观察[J].中西医结合肝病杂志,2004,14(4):202-203. 被引量:4
  • 3任培荣,朵雄,曾令香,吴朝晖,闫兴玲.中西医结合治疗中重度新生儿硬肿症22例临床观察[J].甘肃中医,2007,20(1):31-32. 被引量:3
  • 4李付春,朱翠玲,胡云霞.加味三参汤治疗丙型病毒性肝炎临床报道[J].河南中医,1997,17(2):104-104. 被引量:3
  • 5Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
  • 6Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
  • 7Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
  • 8Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
  • 9Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
  • 10Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.

共引文献754

同被引文献36

  • 1叶放,周仲瑛.周仲瑛教授辨证论治慢性肝炎的经验特色[J].中华中医药杂志,2005,20(10):604-606. 被引量:16
  • 2中华人民共和国卫生部.今天是世界卫生大会倡议的第一个世界肝炎日[EB/OL].[2012-03-25].http://www.moh.gov.cn/pub-liefiles/business/htmlfiles/mohjbyfkzj/s3586/201007/48258.htm.
  • 3Strader DB, Wright T, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C [J 1. Hepatology, 2004, 39(4): 1147- 1171.
  • 4Firpi ILl, Clark V, Soldevila-Pico C, et al. The natural history of hepatitis C cirrhosis after liver transplantation[J~. Liver Transpl, 2009, 15(9):1063-1071.
  • 5Dieterich DT, Rizzetto M, Manns MP. Management of chronic hepa- titis C patients who have relapsed or not responded to pegylated interferon alfa plus RBVavirin[J]. J Viral Hepat, 2009, 16(12): 833-843.
  • 6Orient H, Vrolijk JM, Veldt B J, et al. Hepatitis C 2002 guidelines: summary and annotations[J]. Scand J Gastroenterol Suppl, 2003, (239):105-110.
  • 7Fried MW, Shiffman ML, Reddy KR, et cd. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection[J]. N Engl J Med, 2002, 347(13): 975-982.
  • 8Manns MP, McI4utchison JG, Gordon SC, et al. Peginterferon al- fa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial[J].Lancet, 2001, 358(9286):958-965.
  • 9Zeuzem S, Pawlotsky JM, Lukasiewicz E, et al. International, mul- ticenter, randomized, controlled study comparing dynamically indi- vidualized versus standard treatment in patients with chronic hepa- titis C[J]. J Hepatol, 2005, 43(2):250-257.
  • 10Liu CH, Liu C J, Lin CL, et al. Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controUed trial[J]. Clin Infect Dis, 2008, 47(10):1260-1269.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部